巴里西提尼布治疗异形间歇性肺炎的急性恶化:一项初步研究使用倾向性得分匹配
Hideaki Yamakawa1,2, Shintaro Sato1, Hiroki Ohta1
1Department of Respiratory Medicine, Saitama Red Cross Hospital, Saitama, Japan.
巴里西提尼布在改善间歇性肺病 (AE-ILD) 急性恶化患者的短期存活率方面表现有前途. 这种Janus激酶抑制剂在急性阶段耐受性良好,这表明潜在的治疗益处.
科学领域:
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 间歇性肺病 (AE-ILD) 的急性恶化是一种具有有限治疗选择的危急状况.
- 包括巴里西提尼布在内的雅努斯激酶 (JAK) 抑制剂正在成为严重间歇性肺部疾病 (ILD) 的潜在治疗方法.
研究的目的:
- 评估巴里西提尼布在患有与异常间歇性肺炎 (IIP) 相关的AE-ILD患者的疗效和安全性.
主要方法:
- 一项回顾性队列研究比较了巴里西提尼布治疗的患者与历史对照.
- 倾向分数匹配 (PSM) 用于根据年龄,氧化和纤维化来平衡群体.
- 主要结局是整体生存期;次要结局包括90天生存期和不良事件.
主要成果:
- 在PSM之后,在每个组中分析了17名患者.
- 与对照组 (52.9%,p=0.049) 相比,巴里西提尼布组的90天生存率显著更高 (82.4%).
- 巴里西提尼布与轻度不良事件的耐受性很好;长期存活率没有显著差异.
结论:
- 巴里西提尼布可以提高AE-ILD患者的短期生存率,并且在急性阶段是安全的.
- 该药物的双重JAK1/2抑制提供了潜在的抗炎和抗纤维性作用.
- 需要进一步的前性研究来验证发现并探索组合疗法.
更多相关视频
07:10Direct Intrabronchial Administration to Improve the Selective Agent Deposition Within the Mouse Lung
Published on: May 20, 2019
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
